Regulations.gov document
Biosimilars: Questions and Answers on Biosimilar Development and the Biologics Price…
Notice · FDA-2011-D-0611 · posted Dec 12, 2018
Key facts
| Document ID | FDA-2011-D-0611-0064 |
|---|---|
| Title | Biosimilars: Questions and Answers on Biosimilar Development and the Biologics Price Competition and Innovation Act of 2009; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | Dec 12, 2018 |
| Federal Register citation | 83 FR 63900 |
| FR document number | 2018-26853 |
| Comment period opens | Dec 12, 2018 |
| Effective date | Dec 12, 2018 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: